In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Professor Lale Tokgozoglu
Speaker
Professor Lale Tokgozoglu
Lale Tokgozoglu Lale Tokgozoglu

Hacettepe University, Ankara (Turkey)

Specialities : Risk Factors and Prevention , Acute Coronary Syndromes

Prof. Tokgözoğlu has served on the executive committee of the European Society of Atherosclerosis and is currently the President of the European Atherosclerosis Society. She also served as the president of the ‘Atherosclerosis and Vascular Biology Working Group of the European Society of Cardiology’ between 2008 and 2010. Prof. Tokgözoğlu has served on the board of the Prevention Association of the European Society of Cardiology between 2011-2016. She has been on the European Society of Cardiology Fellowship and Training Committee and the Education Committee. She was the President of the Turkish Society of Cardiology between 2014-2016 after serving on the executive committee for several years. Prof. Tokgözoğlu has been elected to the ‘Science Academy in Turkey’ in 2014. She is on the Editorial Board for European Heart Journal, Atherosclerosis, Anatolian Journal of Cardiology and Archives of the Turkish Society of Cardiology.

24 presentations from this speaker

Current management of dyslipidemia: the tools of the trade.

Event : ESC Congress 2020

  • Session : Preventive Cardiology - Essential Update Part 2
  • Speaker : S Tokgozoglu (Ankara,TR)

Live Q & A with chairmen & speakers.

Event : ESC Congress 2020

  • Session : Add on to take back control: Combining lipid lowering therapies for the management of high risk patients
  • Speaker : S Tokgozoglu (Ankara,TR), J Chapman (Saint Maur,FR)
  • Sponsored by Daiichi Sankyo Europe GmbH

My top 5 innovations - FOCUS on lipidology.

Event : ESC Congress 2020

  • Session : Celebration of the Last Decade of Cardiac Innovation: What Has Been Achieved and What Are the Unmet Needs?
  • Speaker : S Tokgozoglu (Ankara,TR)
  • Joint with the International Society for Cardiovascular Translational Research (ISCTR)

Welcome and introduction.

Event : ESC Congress 2020

  • Session : Add on to take back control: Combining lipid lowering therapies for the management of high risk patients
  • Speaker : J Chapman (Saint Maur,FR), S Tokgozoglu (Ankara,TR)
  • Sponsored by Daiichi Sankyo Europe GmbH

Current management of dyslipidemia: the tools of the trade.

Event : ESC Congress 2019

  • Session : Preventive cardiology: Essential Update Part 2
  • Speaker : S Tokgozoglu (Ankara,TR)

To be or not to be…but at which goal?

Event : ESC Congress 2019

  • Session : Hypercholesterolemia management - What will be our options after tomorrow?
  • Speaker : S Tokgozoglu (Ankara,TR)
  • Sponsored by Mylan

Current LDL-cholesterol goals- Are they appropriate?

Event : ESC Congress 2018

  • Session : LDL goals and inflammation. From basic science to clinical practice.
  • Speaker : S Tokgozoglu (Ankara,TR)

Current management of dyslipidemia: the tools of the trade

Event : ESC Congress 2018

  • Session : Preventive cardiology: review, update, and State of the Art in 2018 - Part 2
  • Speaker : S Tokgozoglu (Ankara,TR)

Panel discussion and Q&A.

Event : ESC Congress 2018

  • Session : Assessing atherosclerosis: risks, goals and strategies to minimize cardiovascular risk post-myocardial infarction
  • Speaker : E Bohula (Boston,US), S Tokgozoglu (Ankara,TR), AK Gitt (Ludwigshafen,DE), H Drexel (Feldkirch,AT)
  • Sponsored by MSD

Targeting treatment for dyslipidemia: goals, guidelines and grades of recommendations.

Event : ESC Congress 2018

  • Session : Assessing atherosclerosis: risks, goals and strategies to minimize cardiovascular risk post-myocardial infarction
  • Speaker : S Tokgozoglu (Ankara,TR)
  • Sponsored by MSD

Challenges for reaching LDL-C goals in high and very high risk patients.

Event : ESC Congress 2017

  • Session : Are we prepared to reduce LDL-cholesterol at any cost?
  • Speaker : S Tokgozoglu (Ankara,TR)
  • Sponsored by Mylan

Conclusion - Are we prepared to reduce LDL-cholesterol at any cost?

Event : ESC Congress 2017

  • Session : Are we prepared to reduce LDL-cholesterol at any cost?
  • Speaker : S Tokgozoglu (Ankara,TR)
  • Sponsored by Mylan

Diploma by chairpersons.

Event : ESC Congress 2017

  • Session : ESC William Harvey Lecture on Basic Science
  • Speaker : S Tokgozoglu (Ankara,TR)

Last step on the ladder: proprotein convertase subtilisin/kexin type 9 (PCSK9).

Event : ESC Congress 2017

  • Session : Are we prepared to reduce LDL-cholesterol at any cost?
  • Speaker : S Tokgozoglu (Ankara,TR)
  • Sponsored by Mylan

Therapies to target the vulnerable plaque: are they the future?

Event : ESC Congress 2017

  • Session : Reducing the danger from atherosclerotic plaque
  • Speaker : S Tokgozoglu (Ankara,TR)
  • Joint with the European Atherosclerosis Society

2016 update on LDL as a risk factor.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2016

  • Session : LDL-Cholesterol lowering at a turning point
  • Speaker : S Tokgozoglu (Ankara,TR)

How to manage a patient with statin intolerance.

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2016

  • Session : Modern management of dyslipidemia: part II
  • Speaker : S Tokgozoglu (Ankara,TR)

LDL vs non HDL cholesterol. Where do we stand?

Event : ESC Congress 2016

  • Session : What has changed since the previous Guidelines in lipidology?
  • Speaker : S Tokgozoglu (Ankara,TR)

Presentation of the awardee

Event : ESC Congress 2016

  • Session : ESC Geoffrey Rose Lecture on Population Sciences
  • Speaker : S Tokgozoglu (Ankara,TR)

Summing up the evidence for daily clinical practice.

Event : ESC Congress 2016

  • Session : The clinical trial update in blood cholesterol management 2016
  • Speaker : S Tokgozoglu (Ankara,TR)
  • Sponsored by MSD

Impact of age (focus on the young and the elderly) and gender (focus on women).

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2015

  • Session : Update on Lipid Lowering Therapy part 1: Why are some patients more difficult to treat with statins than others?
  • Speaker : S Tokgozoglu (Ankara,TR)

Q & A - HoFH - Bad genes, bad lifestyle or bad luck?

Event : ESC Congress 2014

  • Session : Premature heart attacks – Bad lifestyle, bad luck or bad genes?
  • Speaker : S Tokgozoglu (Ankara,TR), E Ros (Barcelona,ES)
  • Sponsored by Aegerion Pharmaceuticals Ltd

What is new on the horizon for these patients?

Event : ESC Congress 2014

  • Session : Familial hypercholesterolaemia - a deadly outcome not a rare disease
  • Speaker : S Tokgozoglu (Ankara,TR)

Fibrates.

Event : ESC Congress 2013

  • Session : Is there a role for non-statin based treatments in dyslipidaemia?
  • Speaker : S Tokgozoglu (Ankara,TR)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are